A. Ferlito et al., LYMPHOEPITHELIAL CARCINOMA OF THE LARYNX, HYPOPHARYNX, AND TRACHEA, The Annals of otology, rhinology & laryngology, 106(5), 1997, pp. 437-444
Lymphoepithelial carcinoma of the larynx, hypopharynx, and trachea is
a rare neoplasm composed of large, poorly differentiated, nonkeratiniz
ed cells intermingled with small nonneoplastic lymphocytes and plasma
cells. It is histologically similar to its more common counterpart occ
urring in the nasopharynx. In contrast to nasopharyngeal carcinoma, mo
st cases have not been associated with Epstein-Barr virus (EBV), altho
ugh rare cases have been reported to be EBV-positive. The diagnosis of
ten requires immunohistochemistry or electron microscopy for confirmat
ion. The neoplasm seems to behave in a fashion reminiscent of nasophar
yngeal carcinoma. Lymph node metastasis occurs in the majority of pati
ents, and eventual visceral dissemination occurs in one fourth. Radiot
herapy is the main treatment for the primary tumor and regional metast
ases, but chemotherapy is indicated for more advanced disease. The ini
tial stage is the primary determinant of prognosis. Death from disease
occurs in about one third of patients.